MARTIN JOHN C 4
4 · GILEAD SCIENCES INC · Filed Dec 4, 2018
Insider Transaction Report
Form 4
MARTIN JOHN C
DirectorChairman and CEO
Transactions
- Gift
Common Stock
2018-11-29−140,000→ 2,877,762 total - Sale
Common Stock
2018-12-03$71.95/sh−13,958$1,004,275→ 2,877,962 total - Exercise/Conversion
Common Stock
2018-12-03$23.60/sh+50,000$1,180,000→ 2,927,762 total - Sale
Common Stock
2018-12-03$70.90/sh−35,842$2,541,370→ 2,891,920 total - Sale
Common Stock
2018-12-03$72.67/sh−200$14,533→ 2,877,762 total - Exercise/Conversion
Non-qualified Stock Option (Right to Buy)
2018-12-03−50,000→ 0 totalExercise: $23.60Exp: 2019-01-21→ Common Stock (50,000 underlying)
Footnotes (6)
- [F1]Shares gifted to charitable trust
- [F2]The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
- [F3]The shares subject to the option have a five year vesting schedule. 20% vest on the first anniversary of the date of the grant. The balance will vest 5% quarterly thereafter until fully vested.
- [F4]Sale prices reported for the transactions reported here range from $70.55 to $71.55. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
- [F5]Sale prices reported for the transactions reported here range from $71.56 to $72.50. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
- [F6]Sale prices reported for the transactions reported here range from $72.59 to $72.74. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.